MedPath
NMPA Approval

Apatinib Mesylate Tablets

国药准字H20140104

September 30, 2019

Drug Information

甲磺酸阿帕替尼片

艾坦

泰舒达

片剂

0.375g(以阿帕替尼计)

化学药品

September 30, 2019

Company Information

Applicant Company

连云港经济技术开发区黄河路38号

Manufacturing Company

连云港经济技术开发区临港产业区东晋路

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

甲磺酸阿帕替尼片 - NMPA 批准文号 | MedPath